Quick Answer
NANOVIRICIDES, INC. reported Cash and Equivalents of $1.56 million for fiscal year 2025.
NANOVIRICIDES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.56M | -67.5% |
| 2024 | $4.80M | -41.1% |
| 2023 | $8.15M | -42.1% |
| 2022 | $14.07M | -31.4% |
| 2021 | $20.52M | +49.7% |
| 2020 | $13.71M | +436.5% |
| 2019 | $2.56M | -63.9% |
| 2018 | $7.08M | -53.1% |
| 2017 | $15.10M | -37.5% |
| 2016 | $24.16M | -23.2% |
| 2015 | $31.47M | -14.2% |
| 2014 | $36.70M | +163.6% |
| 2013 | $13.92M | -2.5% |
| 2012 | $14.27M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $5.15M | +30.1% | +357.5% |
| September 30, 2025 | $1.13M | -70.9% | -27.8% |
| June 30, 2025 | $1.56M | -67.5% | -38.7% |
| March 31, 2025 | $2.54M | -21.9% | -35.8% |
| December 31, 2024 | $3.96M | -24.5% | +2.4% |
| September 30, 2024 | $3.87M | -44.5% | -19.4% |
| June 30, 2024 | $4.80M | -41.1% | +47.3% |
| March 31, 2024 | $3.26M | -66.2% | -37.9% |
- NANOVIRICIDES, INC. showed a decrease of -67.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2025 period, NANOVIRICIDES, INC.’s cash and equivalents has declined by 89.1% (from $14.27 million to $1.56 million).
- The most recent figure is from NANOVIRICIDES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: